3-year update of neoadjuvant atezolizumab plus chemotherapy in patients with resectable non-small cell lung cancer

被引：3
|
作者：
Henick, Brian S.
Gainor, Justin F.
Awad, Mark M.
Chiuzan, Codruta
Izard, Stephanie
Georgis, Yohanna
Koch, Peter D.
Garofano, Robert F.
Wong, Cheryl V.
Saqi, Anjali
Grindheim, Jessica M.
Schulze, Katja
Rizvi, Naiyer A.
Izar, Benjamin
Taylor, Alison M.
Shu, Catherine A.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-CT217
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT217
引用
收藏
页数：3
相关论文
共 50 条
  • [41] The role of neoadjuvant chemotherapy in marginally resectable or unresectable stage III non-small cell lung cancer
    Spásová, I
    Petera, J
    Hytych, V
    NEOPLASMA, 2002, 49 (03) : 189 - 196
  • [42] Neoadjuvant immuno-chemotherapy in resectable non-small cell lung cancer: A retrospective cohort study
    Verma, Saurav
    Vincent, Mark David
    Black, Morgan
    Nayak, Rahul
    Cecchini, Matthew
    Malthaner, Richard
    Raphael, Jacques
    Inculet, Richard
    Fortin, Dalilah
    Blanchette, Philip
    Kuruvilla, Sara
    Qiabi, Mehdi
    Younus, Jawaid
    Breadner, Daniel Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] Single dose of atezolizumab plus chemotherapy in active psoriasis with advanced non-small cell lung cancer
    Wong, Pui Yee
    How, Soon Hin
    Ismail, Irnani
    Hassan, Radhiana
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 471 - 474
  • [44] Patterns of systemic chemotherapy in resectable non-small cell lung cancer
    Dubey, S.
    Su, R.
    Nalbandian, G.
    Hwang, J.
    Jahan, T. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816
    Mitsudomi, Tetsuya
    Ito, Hiroyuki
    Okada, Morihito
    Sugawara, Shunichi
    Shio, Yutaka
    Tomii, Keisuke
    Okami, Jiro
    Sakakura, Noriaki
    Kubota, Kaoru
    Takamochi, Kazuya
    Atagi, Shinji
    Tsuboi, Masahiro
    Oizumi, Satoshi
    Ikeda, Norihiko
    Ohde, Yasuhisa
    Ntambwe, Ives
    Mahmood, Javed
    Cai, Junliang
    Tanaka, Fumihiro
    CANCER SCIENCE, 2024, 115 (02) : 540 - 554
  • [46] Neoadjuvant hypofractionated radiotherapy combined with pembrolizumab plus chemotherapy for potentially resectable non-small cell lung cancer: A phase Ib study
    Ding, Naixin
    Zhao, Lijun
    Zhang, Shuai
    Qiu, Ninglei
    Song, Xue
    Kong, Cheng
    Jiang, Ning
    Zhao, Yang
    Huang, Jianfeng
    Jiang, Feng
    Jiang, Ming
    Zhu, Zihao
    Yin, Rong
    Ren, Binhui
    Zhu, Xiangzhi
    Li, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] The Value of Combined Immunotherapy in Neoadjuvant Regimen for Patients with Resectable Non-small Cell Lung Cancer
    Tian, Y.
    Huang, J.
    Luo, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S577 - S577
  • [48] Meta-Analysis of Neoadjuvant Immunotherapy for Patients with Resectable Non-Small Cell Lung Cancer
    Cao, Christopher
    Le, Anthony
    Bott, Matthew
    Yang, Chi-Fu Jeffrey
    Gossot, Dominique
    Melfi, Franca
    Tian, David H.
    Guo, Allen
    CURRENT ONCOLOGY, 2021, 28 (06) : 4686 - 4701
  • [49] Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer
    Franco, Fernando
    Provencio, Mariano
    JOURNAL OF THORACIC DISEASE, 2019, 11 (10) : 4092 - 4095
  • [50] Neoadjuvant Chemotherapy Plus Immunotherapy in Early-Stage Resectable Non-Small-Cell Lung Cancer
    Passaro, Antonio
    Attili, Ilaria
    de Marinis, Filippo
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (25) : 2871 - 2022
12345